HM-002-1005 is a once-daily oral formulation in development for diabetes, obesity, DKD, frailty and sarcopenia
Employers and health plans must look beyond prescriptions and invest in comprehensive weight health solutionsotherwise, they risk paying for the medication without seeing the full health benefits. Balancing coverage with ROI Even with growing employer-sponsored coverage, cost remains a challenge
Dosing inaccuracy and errors Microdosing has a higher risk of inaccurate dosing and errors
We exist to change that
Potential Benefits of GLP-1s for Heart Health While the focus is often on potential risks, it is important to note that GLP-1 medications may offer significant secondary benefits for individuals already taking blood thinners for cardiovascular reasons
However, when you add GLP-1 medications into the mix, the stakes are higher for potentially losing muscle instead of fat and compromising your overall health